• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
Y0303661 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs Supplementary Application 2003-09-28 中美天津史克制药有限公司 Sino-American Tianjin SmithKline and French Lab Ltd Certificate Issued 2004-06-11 view
X0302522 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs New Drug Application 2003-12-10 浙江尖峰药业有限公司 Zhejiang Jianfeng Pharmaceutical Macutical Holdings Certificate Issued 2004-04-16 view
X0302521 盐酸帕罗西汀 paroxetine hydrochloride Active ingredient Chemical Drugs New Drug Application 2003-12-10 浙江尖峰药业有限公司 Zhejiang Jianfeng Pharmaceutical Macutical Holdings Certificate Issued 2004-04-16 view
X0301078 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs(4) New Drug Application 2003-03-04 浙江华海药业股份有限公司 Zhe JIANG HUA HAI Pharmaceutical Co Ltd Certificate Issued 2003-11-18 view
X0301077 盐酸帕罗西汀 paroxetine hydrochloride Active ingredient Chemical Drugs(4) New Drug Application 2003-03-04 浙江华海药业股份有限公司 Zhe JIANG HUA HAI Pharmaceutical Co Ltd Certificate Issued 2003-11-18 view
JYHZ2100524 盐酸帕罗西汀肠溶缓释片 paroxetine hydrochloride Tablet, extended release Chemical Drugs License Renew 2021-04-21 view
JYHZ2100523 盐酸帕罗西汀肠溶缓释片 paroxetine hydrochloride Tablet, extended release Chemical Drugs License Renew 2021-04-21 view
JYHZ1600113 盐酸帕罗西汀肠溶缓释片 paroxetine hydrochloride Tablet, extended release Chemical Drugs License Renew 2016-05-12 GLAXOSMITHKLINE INC. Glaxosmithkline Inc Certificate Issued 2017-02-04 view
JYHZ1600112 盐酸帕罗西汀肠溶缓释片 paroxetine hydrochloride Tablet, extended release Chemical Drugs License Renew 2016-05-12 GLAXOSMITHKLINE INC. Glaxosmithkline Inc Certificate Issued 2017-02-04 view
JYHS2100054 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs(5.2) Import Drug Application 2021-03-26 阿拉宾度制药有限公司 Aurobindo Pharma Ltd In Review 2021-03-25 view
JYHS2100053 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs(5.2) Import Drug Application 2021-03-26 阿拉宾度制药有限公司 Aurobindo Pharma Ltd In Review 2021-03-25 view
JYHS2100052 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs(5.2) Import Drug Application 2021-03-26 阿拉宾度制药有限公司 Aurobindo Pharma Ltd In Review 2021-03-25 view
JYHS2100051 盐酸帕罗西汀片 paroxetine hydrochloride Tablet Chemical Drugs(5.2) Import Drug Application 2021-03-26 阿拉宾度制药有限公司 Aurobindo Pharma Ltd In Review 2021-03-25 view
JYHB2300321 盐酸帕罗西汀肠溶缓释片 paroxetine hydrochloride Tablet, extended release Chemical Drugs Supplementary Application 2023-05-31 view
JYHB2300320 盐酸帕罗西汀肠溶缓释片 paroxetine hydrochloride Tablet, extended release Chemical Drugs Supplementary Application 2023-05-31 view
JYHB2200521 盐酸帕罗西汀肠溶缓释片 paroxetine hydrochloride Tablet, extended release Chemical Drugs Supplementary Application 2022-09-22 view
JYHB2200520 盐酸帕罗西汀肠溶缓释片 paroxetine hydrochloride Tablet, extended release Chemical Drugs Supplementary Application 2022-09-22 view
JYHB2060031 盐酸帕罗西汀 paroxetine hydrochloride Active ingredient Other Other 2020-05-18 GlaxoSmithKline (China) Investment Co Ltd view
JYHB2001963 盐酸帕罗西汀肠溶缓释片 paroxetine hydrochloride Tablet, extended release Chemical Drugs Supplementary Application 2020-09-30 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2020-11-12 view
JYHB2001962 盐酸帕罗西汀肠溶缓释片 paroxetine hydrochloride Tablet, extended release Chemical Drugs Supplementary Application 2020-09-30 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2020-11-12 view